Abstract
Invasive aspergillosis is the most common invasive mold infection following a hematopoietic cell transplant. Widespread use of antifungal prophylaxis has led to the increasing incidence of cryptic Aspergillus species. Aspergillus calidoustus is one of those emerging species and is notorious for multidrug resistance to antifungals. Here, we report a case of disseminated A. calidoustus infection in a hematopoietic stem cell transplant recipient who was successfully treated with combination therapy that included a novel antifungal.
Original language | English (US) |
---|---|
Article number | e02206-21 |
Journal | Antimicrobial agents and chemotherapy |
Volume | 66 |
Issue number | 3 March |
DOIs | |
State | Published - Mar 2022 |
Keywords
- APX001
- Aspergillus calidoustus
- hematopoietic cell transplant
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases